NeurOp Corporation Announces Extension to Drug Discovery Collaboration with Bristol-Myers Squibb Company

Published: Dec 14, 2011

ATLANTA--(BUSINESS WIRE)--NeurOp, Inc. today announced that Bristol-Myers Squibb (NYSE: BMY) has agreed to fund an additional year of research for NeurOp’s proprietary small molecules for the treatment of major depression and neuropathic pain.

Back to news